Target intelligence / Profile preview

Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) member 2 (SERPINA2)

Target
SERPINA2
Molecular classification
Serine protease inhibitor, SERPIN superfamily, Intracellular glycoprotein
01

Overview

SERPINA2 encodes a member of the serpin family—a group of serine protease inhibitors. It is an intracellular glycoprotein localized to the endoplasmic reticulum, and shares substantial homology with the alpha-1-antitrypsin gene (SERPINA1). Most contemporary human populations carry inactive or deleted alleles, and there is no evidence for a functional extracellular protein in circulation. Phylogenetic analysis suggests SERPINA2 diverged from SERPINA1 in primates and has undergone positive selection, possibly linked to alternative cellular functions in the ER, such as chymotrypsin-like activity or interaction with ER chaperones. SERPINA2 is not associated with known diseases and is not considered a pharmacological target, receptor, or enzyme for drug development. It is sometimes erroneously listed as a functional protein due to its close similarity with alpha-1-antitrypsin, but current evidence places it predominantly as a polymorphic pseudogene with possible intracellular functions.

Other names
Alpha-1-antitrypsin-related proteinARGSATRPILSERPINA2PSerpin A2PsiATRProtease inhibitor 1-likePutative alpha-1-antitrypsin-related proteinAAT-related protein
02

Biological functions

Putative inhibition of serine proteasesPossible chymotrypsin-like activityPossible function as a substrate or adjuvant of ER chaperonesPossible role in fertility or host-pathogen interactions (supported by selection patterns)Protein folding/quality control in the ER
03

Disease associations

No direct disease association establishedGenetic linkage to inflammatory disease loci (e.g., Wegener’s granulomatosis locus, but not functionally implicated)Population studies suggest possible influence but no direct causative disease role
04

Safety considerations

Not applicable—no established therapeutic applications or clinical targets

Beyond the preview

Go deeper on Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) member 2 (SERPINA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) member 2 (SERPINA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call